Daxx is reciprocally regulated by Mdm2 and Hausp

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 542-545

  Tang, Jun ^a   Qu, Like ^b   Pang, Mingsu ^a   Yang, Xiaolu ^c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Daxx; De ubiquitination; Hausp; Mdm2; Ubiquitination

Indexed keywords

DAXX PROTEIN; HERPES VIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; PROTEIN MDM2; PROTEINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 77949261518     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.051     Document Type: Article

References (32)

1. Yang X., Khosravi-Far R., Chang H.Y., and Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89 (1997) 1067-1076
2. Fukuyo Y., Kitamura T., Inoue M., Horikoshi N.T., Higashikubo R., Hunt C.R., Usheva A., and Horikoshi N. Phosphorylation-dependent Lys63-linked polyubiquitination of Daxx is essential for sustained TNF-{alpha}-induced ASK1 activation. Cancer Res. 69 (2009) 7512-7517
3. Khelifi A.F., D'Alcontres M.S., and Salomoni P. Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ. 12 (2005) 724-733
4. Perlman R., Schiemann W.P., Brooks M.W., Lodish H.F., and Weinberg R.A. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3 (2001) 708-714
5. Chen L.Y., and Chen J.D. Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol. Cell Biol. 23 (2003) 7108-7121
6. Torii S., Egan D.A., Evans R.A., and Reed J.C. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18 (1999) 6037-6049
7. Song J.J., and Lee Y.J. Tryptophan 621 and serine 667 residues of Daxx regulate its nuclear export during glucose deprivation. J. Biol. Chem. 279 (2004) 30573-30578
8. Wethkamp N., and Klempnauer K.H. Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta. J. Biol. Chem. 284 (2009) 28783-28794
9. Xue Y., Gibbons R., Yan Z., Yang D., McDowell T.L., Sechi S., Qin J., Zhou S., Higgs D., and Wang W. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. USA 100 (2003) 10635-10640
10. Hollenbach A.D., McPherson C.J., Mientjes E.J., Iyengar R., and Grosveld G. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 115 (2002) 3319-3330
11. Li R., Pei H., Watson D.K., and Papas T.S. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19 (2000) 745-753
12. Tang J., Wu S., Liu H., Stratt R., Barak O.G., Shiekhattar R., Picketts D.J., and Yang X. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J. Biol. Chem. 279 (2004) 20369-20377
13. Saffert R.T., and Kalejta R.F. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80 (2006) 3863-3871
14. Cantrell S.R., and Bresnahan W.A. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J. Virol. 80 (2006) 6188-6191
15. Hwang J., and Kalejta R.F. Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367 (2007) 334-338
16. Lukashchuk V., McFarlane S., Everett R.D., and Preston C.M. Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 82 (2008) 12543-12554
17. Tang J., Qu L.K., Zhang J., Wang W., Michaelson J.S., Degenhardt Y.Y., El-Deiry W.S., and Yang X. Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 8 (2006) 855-862
18. Zhao L.Y., Liu J., Sidhu G.S., Niu Y., Liu Y., Wang R., and Liao D. Negative regulation of p53 functions by Daxx and the involvement of MDM2. J. Biol. Chem. 279 (2004) 50566-50579
19. Michaelson J.S., Bader D., Kuo F., Kozak C., and Leder P. Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev. 13 (1999) 1918-1923
20. Ryo A., Hirai A., Nishi M., Liou Y.C., Perrem K., Lin S.C., Hirano H., Lee S.W., and Aoki I. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. J. Biol. Chem. 282 (2007) 36671-36681
21. Ecsedy J.A., Michaelson J.S., and Leder P. Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity. Mol. Cell Biol. 23 (2003) 950-960
22. Kwon J.E., La M., Oh K.H., Oh Y.M., Kim G.R., Seol J.H., Baek S.H., Chiba T., Tanaka K., Bang O.S., Joe C.O., and Chung C.H. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase. J. Biol. Chem. 281 (2006) 12664-12672
23. Fu W., Ma Q., Chen L., Li P., Zhang M., Ramamoorthy S., Nawaz Z., Shimojima T., Wang H., Yang Y., Shen Z., Zhang Y., Zhang X., Nicosia S.V., Zhang Y., Pledger J.W., Chen J., and Bai W. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J. Biol. Chem. 284 (2009) 13987-14000
24. Yang J.Y., Zong C.S., Xia W., Wei Y., Li-Seyed M., Li Z., Broglio K., Berry D.A., and Hung M.C. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol. Cell Biol. 26 (2006) 7269-7282
25. Li M., Brooks C.L., Kon N., and Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13 (2004) 879-886
26. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., and Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 (2002) 648-653
27. Momand J., Jung D., Wilczynski S., and Niland J. The MDM2 gene amplification database. Nucleic Acids Res. 26 (1998) 3453-3459
28. Wang H., Oliver P., Zhang Z., Agrawal S., and Zhang R. Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms. Ann. NY Acad. Sci. 1002 (2003) 217-235
29. Moller M.B., Nielsen O., and Pedersen N.T. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities. Mod. Pathol. 12 (1999) 1010-1016
30. Bouska A., and Eischen C.M. Mdm2 affects genome stability independent of p538. Cancer Res. 69 (2009) 1697-1701
31. Miwa S., Uchida C., Kitagawa K., Hattori T., Oda T., Sugimura H., Yasuda H., Nakamura H., Chida K., and Kitagawa M. Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner. Biochem. Biophys. Res. Commun. 340 (2006) 54-61
32. McDonough H., Charles P.C., Hilliard E.G., Qian S.B., Min J.N., Portbury A., Cyr D.M., and Patterson C. Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program. J. Biol. Chem. 284 (2009) 20649-20659